RISK OF HEPATOCELLULAR CANCER AFTER VIROLOGICAL CURE WITH DIRECT ACTING ANTIVIRAL AGENTS IN INDIVIDUALS WITH HEPATITIS C

The General Hospital Corporation

Investigators